Catalytic Impact Foundation
Overview
Catalytic Impact Foundation (CIF) is a mission-driven, 501(c)(3) non-profit venture capital firm that aggregates and invests philanthropic capital into early-stage life sciences and healthcare companies. It aims to accelerate innovations that address unmet medical needs, particularly in underfunded areas such as women's health, brain health, children's health, rare diseases, and aging. The foundation employs an evergreen fund model it terms "regenerative philanthropy," where returns from investments are reinvested into the fund to support new companies. CIF operates with the discipline of traditional venture capital, making equity investments in pre-seed, seed, and Series A stage companies across North America, Europe, and Israel.
Portfolio Companies
15
Website
cifimpact.orgInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Flourish Care | Mar 2026 | Seed | Co-investor |
| Limax Biosciences | Mar 2025 | Angel | Lead |
| Egal Pads | Jan 2025 | Series A | Co-investor |
| Terran Biosciences | Feb 2024 | Series B | Co-investor |
| Stingray Therapeutics | Jan 2023 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.